Characterizing the specificity of activated Factor XIII for glutamine-containing substrate peptides

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1764, Issue 7, 2006, Pages 1207-1217

  Cleary, David B ^a   Maurer, Muriel C ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Coagulation; Deamidation; Factor XIII; Kinetic; NMR; Transglutaminase

Indexed keywords

ALPHA 2 ANTIPLASMIN; BETA CASEIN; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8A; GLUTAMINE; LYSINE; PEPTIDE;

ARTICLE; CLINICAL RESEARCH; DEAMINATION; ENZYME ACTIVATION; ENZYME BINDING; ENZYME MECHANISM; ENZYME SPECIFICITY; ENZYME SUBSTRATE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICHAELIS CONSTANT; MICHAELIS MENTEN KINETICS; MOLECULAR MODEL; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN PROTEIN INTERACTION;

AMINO ACID SEQUENCE; ANTIPLASMIN; BINDING SITES; CASEINS; CATALYSIS; FACTOR XIIIA; GLUTAMINE; HUMANS; KINETICS; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR SEQUENCE DATA; PEPTIDES; RECOMBINANT PROTEINS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SUBSTRATE SPECIFICITY;

EID: 33746040431     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2006.05.003     Document Type: Article

References (42)

1. Mosesson M.W., Siebenlist K.R., and Meh D.A. The structure and biological features of fibrinogen and fibrin. Ann. N. Y. Acad. Sci. 936 (2001) 11-30
2. Muszbek L., Yee V.C., and Hevessy Z. Blood coagulation Factor XIII: structure and function. Thromb. Res. 94 (1999) 271-305
3. Lorand L. Factor XIII: structure, activation and interactions with fibrinogen and fibrin. Ann. N. Y. Acad. Sci. 936 (2001) 291-311
4. Ariens R.A.S., Lai T.-S., Weisel J.W., Greenberg C.S., and Grant P.J. Role of Factor XIII in fibrin clot formation and effects of genetic polymorphisms. Blood 100 (2002) 743-754
5. Lorand L., and Graham R.M. Transglutaminases: crosslinking enzymes with pleiotropic functions. Nat. Rev., Mol. Cell Biol. 4 (2003) 140-156
6. Lynch G.W., and Pfueller S.L. Thrombin-independent activation of platelet Factor XIII by endogenous platelet acid protease. Thromb. Haemost. 59 (1988) 372-377
7. Ando Y., Imamura S., Yamagata Y., Kitahara A., Saji H., Murachi T., and Kannagi R. Platelet Factor XIII is activated by calpain. Biochem. Biophys. Res. Commun. 144 (1987) 484-490
8. Folk J.E. Mechanism and basis for specificity of transglutaminase-catalyzed epsilon-(gamma-glutamyl) lysine bond formation. Adv. Enzymol. 54 (1983) 1-56
9. Lorand L., and Conrad S.M. Transglutaminases. Mol. Cell. Biochem. 58 (1984) 9-35
10. Yee V.C., Pederson L.C., Le Trong I., Bishop P.D., Stenkamp R.E., and Teller D.C. Three-dimensional structure of a transglutaminase: human blood coagulation Factor XIII. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 7296-7300
11. Pedersen L.C., Yee V.C., Bishop P.D., Le Trong I., Terrler D.C., and Stenkamp R.E. Transglutaminase Factor XIII uses proteinase-like catalytic triad to crosslink macromolecules. Protein Sci. 3 (1994) 1131-1135
12. Yee V.C., Le Trong I., Bishop P.D., Pedersen L.C., Stenkamp R.E., and Teller D.C. Structure and function studies of Factor XIIIa by X-ray crystallography. Semin. Thromb. Hemost. 22 (1996) 377-384
13. Chen R., and Doolittle R.F. γ-γ Cross-linking sites in human and bovine fibrin. Biochemistry 10 (1971) 4486-4491
14. Matsuka Y.V., Medved L.V., Migliorini M.M., and Ingham K.C. Factor XIIIa-catalyzed crosslinking of recombinant alpha C fragments of human fibrinogen. Biochemistry 35 (1996) 5810-5816
15. Ritchie H., Lawrie L.C., Crombie P.W., Mosesson M.W., and Booth N.A. Cross-linking of plasmingoen activator inhibitor 2 and alpha2-antiplasmin to fibrin(ogen). J. Biol. Chem. 275 (2000) 24915-24920
16. Procyk R., and Blomback B. Factor XIII-induced crosslinking in solutions of fibrinogen and fibronectin. Biochim. Biophys. Acta 967 (1988) 304-313
17. Barry E.L., and Mosher D.F. Factor XIIIa-mediated cross-linking of fibronectin in fibroblast cell layers. Cross-linking of cellular and plasma fibronectin and of amino-terminal fibronectin fragments. J. Biol. Chem. 264 (1989) 4179-4185
18. Severina E., Nunez L., Baker S., and Matuska Y.V. Factor XIIIa mediated attachment of S. aureus fibronectin-binding protein A (FnbA) to fibrin: identification of Gln103 as a major cross-linking site. Biochemistry 45 (2006) 1870-1880
19. Jensen P.H., Schuler E., Woodrow G., Richardson M., Goss N., Hojrup P., Petersen T.E., and Rasmussen L.K. A unique interhelical insertion in plasminogen activator inhibitor-2 contains three glutamines Gln83, Gln84, Gln86, essential for transglutaminase-mediated cross-linking. J. Biol. Chem. 269 (1994) 15394-15398
20. Valnickova Z., and Enghild J.J. Human procarboxypeptidase U, or thrombin-activable fibrinolysis inhibitor, is a substrate for transglutaminases. J. Biol. Chem. 273 (1998) 27220-27224
21. Skorstengaard K., Halkier T., Hojrup P., and Mosher D. Sequence location of a putative transglutaminase cross-linking site in human vitronectin. FEBS Lett. 262 (1990) 269-274
22. McDonagh J., and Fukue H. Determinants of substrate specificity for Factor XIII. Semin. Thromb. Hemost. 22 (1996) 369-376
23. Grootjans J.J., Groenen P.J., and de Jong W.W. Substrate requirements for transglutaminases: influence of the amino acids preceding the amine donor lysine in a native protein. J. Biol. Chem. 270 (1995) 22855-22858
24. Gorman J.J., and Folk J.E. Structural features of glutamine substrates for transglutamines. Specificities of human plasma Factor XIIIa and the guinea pig liver enzyme toward synthetic peptides. J. Biol. Chem. 256 (1981) 2712-2715
25. Marinescu A., Cleary D.B., Littlefield T.R., and Maurer M.C. Structural features associated with the binding of glutamine-containing peptides to Factor XIII. Arch. Biochem. Biophys. 406 (2002) 9-20
26. Bishop P.D., Teller D.C., Smith R.A., Lasser G.W., Gilbert T., and Seale R.L. Expression, purification, and characterization of human Factor XIII in Saccharomyces cerevisiae. Biochemistry 29 (1990) 1861-1869
27. Curtis C.G., Brown R.B., Credo R.A., Domanik A.G., Stenberg P., and Lorand L. Calcium-dependent unmasking of active center cysteine during activation of fibrin stabilizing factor. Biochemistry 13 (1974) 3774-3780
28. Campbell A.P., and Sykes B.D. The two-dimensional transferred nuclear Overhauser effect: theory and practice. Annu. Rev. Biophys. Biomol. Struct. 22: (1993) 99-122
29. Fickenscher K., Aab A., and Stüber W. A photometric assay for blood coagulation Factor XIII. Thromb. Haemost. 65 (1991) 535-540
30. Karpati L., Penke B., Katona E., Balogh I., Vamosi G., and Muszbek L. A modified, optimized kinetic photometric assay for the determination of blood coagulation Factor XIII activity in plasma. Clin. Chem. 46 (2000) 1946-1955
31. Trumbo T.A., and Maurer M.C. Examining thrombin hydrolysis of the Factor XIII activation peptide segment leads to a proposal for explaining the cardioprotective effects observed with the Factor XIII V34L mutation. J. Biol. Chem. 275 (2000) 20627-20631
32. Cleary D.B., Trumbo T.A., and Maurer M.C. Protease-activated receptor 4-like peptides bind to thrombin through an optimized interaction with the enzyme active site surface. Arch. Biochem. Biophys. 403 (2002) 179-188
33. Martinelli R.A., and Scheraga H.A. Assay of bovine fibrinopeptides by high performance liquid chromatography. Anal. Biochem. 96 (1979) 246-249
34. Gorman J.J., and Folk J.E. Structural features of glutamine substrates for human plasma Factor XIIIa (activated blood coagulation Factor XIII). J. Biol. Chem. 255 (1980) 419-427
35. Karpati L., Penke B., Katona E., Balogh I., Vamosi G., and Muszbek L. A modified, optimized kinetic photometric assay for the determination of blood coagulation Factor XIII activity in plasma. Clin. Chem. 46 (2000) 1946-1955
36. Lee K.N., Jackson K.W., Christiansen V.J., Chung K.H., and McKee P.A. A novel plasma proteinase potentiates alpha2-antiplasmin inhibition of fibrin digestion. Blood 103 (2004) 3783-3788
37. Lee K.N., Lee C.S., Tae W.-C., Jackson K.W., Christiansen V.J., and McKee P.A. Crosslinking of wild-type and mutant alpha2-antiplasmins to fibrin by activated Factor XIII and by a tissue transglutaminase. J. Biol. Chem. 275 (2000) 37382-37389
38. Ichinose A., Tamaki T., and Aoki N. Factor XIII-mediated cross-linking of NH2-terminal peptide of alpha2 plasmin inhibitor to fibrin. FEBS Lett. 153 (1983) 369-371
39. Kimura S., Tamaki T., and Aoki N. Acceleration of fibrinolysis by the N-terminal peptide of alpha 2-plasmin inhibitor. Blood 66 (1985) 157-160
40. Shan L., Molberg O., Parrot I., Hausch F., Filiz F., Gray G.M., Sollid L.M., and Khosla C. Structural Basis for gluten intolerance in celiac sprue. Science 297 (2002) 2275-2279
41. Molberg O., McAdam S.N., Korner R., Quarsten H., Kristiansen C., Madsen L., Fugger L., Scott H., Noren O., Roepstorff P., Lundin K.E., Sjostrom H., and Sollid L.M. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat. Med. 4 (1998) 713-717
42. Fleckenstein B., Molberg O., Qiao S.W., Schmid D.G., von der Mulbe F., Elgstoen K., Jung G., and Sollid L.M. Gliadin T cell iptope selection by tissue transglutaminase in celiac disease. Role of enzyme specificity and pH influence on the transamidation versus deamidation process. J. Biol. Chem. 277 (2002) 34109-34116